Investigational New Drugs · 2020 · 19 citations · 21 references
MedicineImmunologyOncologyCancer PharmacologyMolecular OncologyNeoplasiaGrowth Factor Receptor OncogenesNeutropenia ManagementNeutrophil BiologyReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsEgfr InhibitionErlotinib TherapyNeutrophil InvolvementNeutrophil-to-lymphocyte RatioOncogenic Receptor Tyrosine Kinase MutationsTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase Inhibitor Therapy
21
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.3K citations · Full text
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text